Aralez Pharmaceuticals US Inc. Bankruptcy Docket

Cases

Plan confirmed May 7, 2019

Updated Oct 3, 5:05 PM ET

Petition filed
Aug 10, 2018
Plan confirmed
May 7, 2019

Aralez Pharmaceuticals US Inc.’s Chapter 11 case was closed on October 2, 2019, under the final decree Dkt. 743. The case followed a liquidating-plan path: the court confirmed the plan on May 7, 2019, and the May 17 effectiveness notice Dkt. 688 reported that it had become effective.

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Key firms

Alvarez & Marsal Healthcare Industry Group, LLCFinancial Advisor
Berkeley Research GroupFinancial Advisor
Dundon Advisers LLCFinancial Advisor
Moelis & CompanyInvestment Banker

Recent filings

Oct 17Quarterly Operating Report for the Period July 1, 2019 through September 30, 2019 Filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc., et al..Bankr. S.D.N.Y., No. 18-12425, ECF No. 745Dkt. 745
Oct 2Order of Final Decree, signed on 10/2/2019, Closing Chapter 11 Case (Case no. 18-12425) and Granting Related Relief (Related Doc # 739).Bankr. S.D.N.Y., No. 18-12425, ECF No. 743Dkt. 743
Oct 2Order Signed on 10/2/2019 Authorizing Clerk's Office to Dispose of Sealed Materials. (related document(s)741)Bankr. S.D.N.Y., No. 18-12425, ECF No. 742Dkt. 742
Sep 23Notice of Presentment of Motion for Order Authorizing Clerk's Office to Dispose of Any Hard Copies or Electronic Storage Devices with Documents Filed Under Seal filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc., et al.. with presentment to be held on 9/30/2019 at 12:00 PM at Courtroom 523 (MG) Objections due by 9/30/2019,Bankr. S.D.N.Y., No. 18-12425, ECF No. 741Dkt. 741
Sep 16Application for Final Decree / Motion for Final Decree Closing Chapter 11 Case and Granting Related Relief filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc., et al. Responses due by 9/23/2019, with presentment to be held on 9/23/2019 at 12:00 PM at Courtroom 523 (MG).Bankr. S.D.N.Y., No. 18-12425, ECF No. 739Dkt. 739
Sep 3Transcript regarding Hearing Held on 07/31/2019 at 11:15 am RE: (CC: Doc# 713, 733) Final Application for Final Professional Compensation Sixth Monthly and Final Application of Berkeley Research Group, LLC for Compensation for Services Rendered and Reimbursement of Expenses as Co-Financial Advisor to the Official Committee of Unsecured Creditors During the Period from August 27, 2018 through June 21, 2019 for Official Committee of Unsecured Creditors, Other Professional, period: 8/27/2018 to 6/21/2019, fee: $585,796.50, expenses: $353.50...et al. Remote electronic access to the transcript is restricted until 12/2/2019. The transcript may be viewed at the Bankruptcy Court Clerks Office. [Transcription Service Agency: eScribers, LLC.]. (See the Courts Website for contact information for the Transcription Service Agency.) (RE: related document(s) 721, 733, 712, 717, 727, 725, 728, 723, 713, 715, 724, 722, 716, 726, 714). Notice of Intent to Request Redaction Deadline Due By 9/10/2019. Statement of Redaction Request Due By 9/24/2019. Redacted Transcript Submission Due By 10/4/2019. Transcript access will be restricted through 12/2/2019. (Lewis, Tenille) (Entered: 09/11/2019)Bankr. S.D.N.Y., No. 18-12425, ECF No. 738Dkt. 738

Full docket (735) →

Case facts and filing dates come from court records.

Plan confirmed May 7, 2019

Updated Oct 3, 5:05 PM ET

Petition filed
Aug 10, 2018
Plan confirmed
May 7, 2019

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Key firms

Alvarez & Marsal Healthcare Industry Group, LLCFinancial Advisor
Berkeley Research GroupFinancial Advisor
Dundon Advisers LLCFinancial Advisor
Moelis & CompanyInvestment Banker

Recent filings

Oct 17Quarterly Operating Report for the Period July 1, 2019 through September 30, 2019 Filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc., et al..Bankr. S.D.N.Y., No. 18-12425, ECF No. 745Dkt. 745
Oct 2Order of Final Decree, signed on 10/2/2019, Closing Chapter 11 Case (Case no. 18-12425) and Granting Related Relief (Related Doc # 739).Bankr. S.D.N.Y., No. 18-12425, ECF No. 743Dkt. 743
Oct 2Order Signed on 10/2/2019 Authorizing Clerk's Office to Dispose of Sealed Materials. (related document(s)741)Bankr. S.D.N.Y., No. 18-12425, ECF No. 742Dkt. 742
Sep 23Notice of Presentment of Motion for Order Authorizing Clerk's Office to Dispose of Any Hard Copies or Electronic Storage Devices with Documents Filed Under Seal filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc., et al.. with presentment to be held on 9/30/2019 at 12:00 PM at Courtroom 523 (MG) Objections due by 9/30/2019,Bankr. S.D.N.Y., No. 18-12425, ECF No. 741Dkt. 741
Sep 16Application for Final Decree / Motion for Final Decree Closing Chapter 11 Case and Granting Related Relief filed by Paul V. Shalhoub on behalf of Aralez Pharmaceuticals US Inc., et al. Responses due by 9/23/2019, with presentment to be held on 9/23/2019 at 12:00 PM at Courtroom 523 (MG).Bankr. S.D.N.Y., No. 18-12425, ECF No. 739Dkt. 739
Sep 3Transcript regarding Hearing Held on 07/31/2019 at 11:15 am RE: (CC: Doc# 713, 733) Final Application for Final Professional Compensation Sixth Monthly and Final Application of Berkeley Research Group, LLC for Compensation for Services Rendered and Reimbursement of Expenses as Co-Financial Advisor to the Official Committee of Unsecured Creditors During the Period from August 27, 2018 through June 21, 2019 for Official Committee of Unsecured Creditors, Other Professional, period: 8/27/2018 to 6/21/2019, fee: $585,796.50, expenses: $353.50...et al. Remote electronic access to the transcript is restricted until 12/2/2019. The transcript may be viewed at the Bankruptcy Court Clerks Office. [Transcription Service Agency: eScribers, LLC.]. (See the Courts Website for contact information for the Transcription Service Agency.) (RE: related document(s) 721, 733, 712, 717, 727, 725, 728, 723, 713, 715, 724, 722, 716, 726, 714). Notice of Intent to Request Redaction Deadline Due By 9/10/2019. Statement of Redaction Request Due By 9/24/2019. Redacted Transcript Submission Due By 10/4/2019. Transcript access will be restricted through 12/2/2019. (Lewis, Tenille) (Entered: 09/11/2019)Bankr. S.D.N.Y., No. 18-12425, ECF No. 738Dkt. 738

Full docket (735) →

Case facts and filing dates come from court records.